mTOR complex 2 (mTORC2) signaling is upregulated in multiple types of human cancer, but the molecular mechanisms underlying its activation and regulation remain elusive. Here, we show that microRNA-mediated upregulation of Rictor, an mTORC2-specific component, contributes to tumor progression. Rictor is upregulated via the repression of the miR-424/503 cluster in human prostate and colon cancer cell lines that harbor c-Src upregulation and in Src-transformed cells. The tumorigenicity and invasive activity of these cells were suppressed by re-expression of miR-424/503. Rictor upregulation promotes formation of mTORC2 and induces activation of mTORC2, resulting in promotion of tumor growth and invasion. Furthermore, downregulation of miR-424/503 is associated with Rictor upregulation in colon cancer tissues. These findings suggest that the miR-424/503–Rictor pathway plays a crucial role in tumor progression.

Precisely regulated spatiotemporal gene expression is essential for the establishment of neural circuits. In contrast to the increasing evidence for transcriptional regulation of axon guidance cues and receptors, the role of posttranscriptional regulation in axon guidance, especially in vivo, remains poorly characterized. Here, we demonstrate that the expression of Slit receptor Robo3/Rig-1, which plays crucial roles in axonal midline crossing, is regulated by a neural RNA-binding protein Musashi1 (Msi1). Msi1 binds to Robo3 mRNA through RNA recognition motifs and increases the protein level of Robo3 without affecting its mRNA level. In Msi1-deficient precerebellar neurons, Robo3 protein, but not its mRNA, is dramatically reduced. Moreover, similar to defects in Robo3-deficient mice, axonal midline crossing and neuronal migration of precerebellar neurons are severely impaired in Msi1-deficient mice. Together, these findings indicate that Msi1-mediated posttranscriptional regulation of Robo3 controls midline crossing of precerebellar neurons.

The activity of the mechanistic target of rapamycin (mTOR) is elevated in various types of human cancers, implicating a role in tumor progression. However, the molecular mechanisms underlying mTOR upregulation remain unclear. In this study, we found that the expression of mLST8, a required subunit of both mTOR complex 1 (mTORC1) and complex 2 (mTORC2), was upregulated in several human colon and prostate cancer cell lines and tissues. Knockdown of mLST8 significantly suppressed mTORC1 and mTORC2 complex formation, and it also inhibited tumor growth and invasiveness in human colon carcinoma (HCT116) and prostate cancer (LNCaP) cells. Overexpression of mLST8 induced anchorage-independent cell growth in normal epithelial cells (HaCaT), although mLST8 knockdown had no effect on normal cell growth. mLST8 knockdown reduced mTORC2-mediated phosphorylation of AKT in both cancer and normal cells, whereas it potently inhibited mTORC1-mediated phosphorylation of 4E-BP1 specifically in cancer cells. These results suggest that mLST8 plays distinct roles in normal and cancer cells, depending upon its expression level, and that mLST8 upregulation may contribute to tumor progression by constitutively activating both the mTORC1 and mTORC2 pathways.

Neuronal Elav-like (nElavl or neuronal Hu) proteins are RNA-binding proteins that regulate RNA stability and alternative splicing, which are associated with axonal and synaptic structures. nElavl proteins promote the differentiation and maturation of neurons via their regulation of RNA. The functions of nElavl in mature neurons are not fully understood, although Elavl3 is highly expressed in the adult brain. Furthermore, possible associations between nElavl genes and several neurodegenerative diseases have been reported. We investigated the relationship between nElavl functions and neuronal degeneration using Elavl3−/− mice. Elavl3−/− mice exhibited slowly progressive motor deficits leading to severe cerebellar ataxia, and axons of Elavl3−/− Purkinje cells were swollen (spheroid formation), followed by the disruption of synaptic formation of axonal terminals. Deficit in axonal transport and abnormalities in neuronal polarity was observed in Elavl3−/− Purkinje cells. These results suggest that nElavl proteins are crucial for the maintenance of axonal homeostasis in mature neurons. Moreover, Elavl3−/− mice are unique animal models that constantly develop slowly progressive axonal degeneration. Therefore, studies of Elavl3−/− mice will provide new insight regarding axonal degenerative processes.

Human diploid fibroblasts (HDF) immortalized by hTERT and simian virus 40 (SV40) early region (ER) exhibit a limited degree of transformation upon the expression of activated H-RAS (H-RAShuman diploid fibroblast ͉ mitogen-activated protein kinase kinase͞extracellular signal-regulated kinase ͉ simian virus 40 early region ͉ telomerase ͉ rat embryonic fibroblasts I n contrast to rodent cells, human cells have long been very difficult to be transformed in vitro. Normal (nonestablished) rodent cells can be readily transformed by the concomitant expression of two oncogenes, whereas normal human cells have proven to be resistant to the transformation induced by the same combinations of oncogenes, indicating the fundamental differences in cellular requirements for oncogenic transformation between these species. In 1999, Weinberg and colleagues (1) reported that ectopic expression of the catalytic subunit of human telomerase (hTERT) made normal human foreskin fibroblasts and kidney epithelial cells susceptible to transformation by the combined expression of simian virus 40 (SV40) early region (SV40 ER) and activated H-Ras (H-Ras V12). They further succeeded in transforming several different types of normal human cells by the same combinations of genetic elements. Based on these results, they proposed that the telomere maintenance by hTERT, inactivation of p53 and retinoblastoma (Rb) by SV40 large T antigen, suppression of protein phosphatase PP2A activity by SV40 small t antigen, and constitutive activation of mitogenic signaling by activated Ras are sufficient to transform normal human cells (2). However, we recently demonstrated that, even when all these requirements are fulfilled, the transformed phenotypes of human fibroblasts are much less malignant than those of rat fibroblasts in terms of morphological changes, anchorage independence, and tumorigenicity in nude mice (3, 4). Our results strongly suggest that normal human cells have still undefined intrinsic mechanisms rendering them resistant to oncogenic transformation. In the present study, we found that the expression of FRA1, a member of the family of AP-1 transcription factors, was differentially regulated by RAS in human and rat fibroblasts and concluded that this transcription factor is one of the determinant factors for species-specific susceptibility to RAS-induced transformation. Results FRA1 Is Highly Induced by RAS in Rodent Fibroblasts but Not in HumanFibroblasts. To explore the molecular basis underlying the difference in RAS-induced transformation phenotypes between rodent and human fibroblasts, we performed gene expression profiling by using a CodeLink microarray. Rat embryonic fibroblasts (REF), mouse embryonic fibroblasts (MEF) and a strain of human diploid fibroblasts (HDF), TIG3 ectopically expressing hTERT (TIG3͞T), were analyzed. We made comparisons between cells expressing SV40 ER (S) alone and cells coexpressing SV40 ER and H-Ras V12 (SR), because the drastic phenotypic differences between rodent and human fibroblasts were observed in respo...